Migraine Drugs Market Is Registering a Healthy 3.5% CAGR Between 2017 and 2025
The global migraine drugs market is highly competitive and consolidated due to presence of strong players, finds Transparency Market Research (TMR). Some of the key players operating in the global migraine drugs market. Some of the leading players in the global migraine drugs market includes AstraZeneca Plc., Pfizer, Inc., Allergan Plc., Teva Pharmaceutical Industries Ltd., Eli Lilly & Co., GlaxoSmithKline plc, Novartis AG, Valeant Pharmaceutical International, Inc., Merck & Co., Inc., Janssen Pharmaceutical Company, Zosano Pharma Corporation, Endo Pharmaceuticals Inc.,...
View full press release